These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1350774)
41. Nebulised salbutamol: an antidote for beta blockers. Arora P; Kumar V; Dubey NK; Mahesh K Indian Pediatr; 1999 Jun; 36(6):591-3. PubMed ID: 10736590 [No Abstract] [Full Text] [Related]
42. Recurrent symptomatic bradycardia due to secret ingestion of beta-blockers--a rare manifestation of cardiac Münchhausen syndrome. Steinwender C; Hofmann R; Kypta A; Leisch F Wien Klin Wochenschr; 2005 Sep; 117(18):647-50. PubMed ID: 16416348 [TBL] [Abstract][Full Text] [Related]
43. Poisoning with calcium channel blockers--a case report and review of the literature. Amorim S; Dias P; Rocha G; Gama G; de Campos M; Pires S Rev Port Cardiol; 2001 Dec; 20(12):1249-57. PubMed ID: 11865685 [TBL] [Abstract][Full Text] [Related]
44. [Sinusal dysfunction secondary to the ingestion of diltiazem, cured by the administration of intravenous calcium]. Andrivet P; Fechner J; Lordez JM; Fournier C; Blondeau M Ann Fr Anesth Reanim; 1987; 6(1):45-7. PubMed ID: 3578945 [TBL] [Abstract][Full Text] [Related]
45. [Adverse effects and toxicity of beta blockers]. Bosković B; Dobrić S; Stojiljković MP Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():74-80. PubMed ID: 18193817 [TBL] [Abstract][Full Text] [Related]
46. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction. Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511 [TBL] [Abstract][Full Text] [Related]
47. Glucagon: a first-line drug for cardiotoxicity caused by beta blockade. Daley KA; Ruksnaitis N J Emerg Nurs; 1986; 12(6):387-92. PubMed ID: 2879063 [No Abstract] [Full Text] [Related]